Cargando…
Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution
[Image: see text] An acyl-CoA:cholesterol O-acyltransferase-1 (ACAT-1/SOAT-1) inhibitor, K-604 is a promising drug candidate for the treatment of Alzheimer’s disease and glioblastoma; however, it exhibits poor solubility in neutral water and low permeability across the blood–brain barrier. In this s...
Autores principales: | Shibuya, Kimiyuki, Morikawa, Shigeru, Miyamoto, Masayoshi, Ogawa, Shin-ichiro, Tsunenari, Yoshihiko, Urano, Yasuomi, Noguchi, Noriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796924/ https://www.ncbi.nlm.nih.gov/pubmed/31646241 http://dx.doi.org/10.1021/acsomega.9b02307 |
Ejemplares similares
-
Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA:cholesterol acyltransferase 1
por: Yamanaka, K, et al.
Publicado: (2014) -
A simple method to disrupt and restore subunit interaction of acyl-CoA:cholesterol acyltransferase 1
por: Neumann, Bryan, et al.
Publicado: (2019) -
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint
por: Schmidt, Nathalie M., et al.
Publicado: (2021) -
Reversible translocation of acyl-CoA:cholesterol acyltransferase (ACAT) between the endoplasmic reticulum and vesicular structures
por: Schiffmann, Andrea, et al.
Publicado: (2023) -
Polymorphism of rs1044925 in the acyl-CoA:cholesterol acyltransferase-1 gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations
por: Wu, Dong-Feng, et al.
Publicado: (2010)